Effie Kuti

Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial

Odette S. Reifsnider, Christoph Wanner, Egon Pfarr et al. · American Journal of Kidney Diseases · 2021 · 45 citations · Full text

Empa-reg Outcome Trial, United States, Renal Function +22

Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease

Sandhya Mehta, Sabyasachi Ghosh, Stephen Sander et al. · Journal of Managed Care & Specialty Pharmacy · 2018 · 32 citations · Full text

Length of Stay and Hospital Costs Associated with a Pharmacodynamic‐Based Clinical Pathway for Empiric Antibiotic Choice for Ventilator‐Associated Pneumonia

Anthony M. Nicasio, Kathryn J. Eagye, Effie Kuti et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2010 · 31 citations

Student Measurement of Blood Pressure Using a Simulator Arm Compared with a Live Subject's Arm

Jennifer J. Lee, Diana M Sobieraj, Effie Kuti · American Journal of Pharmaceutical Education · 2010 · 20 citations · Full text

Hypertension, Kinesiology, Health Sciences +10

Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both

Chi Nguyen, Rakesh Luthra, Effie Kuti et al. · Current Medical Research and Opinion · 2020 · 13 citations